National Institute for Health and Clinical Excellence (NICE)
Shared Learning Awards 2020 finalist: Bronchiolitis: when less is more
The Shared Learning Awards recognise the brilliant work being done to put NICE guidance and standards into practice in a range of organisations, including NHS, local authorities, and the voluntary sector. The following work has been shortlisted for the NICE Shared Learning Awards 2020 and represents one of our 3 finalists.
Shared learning example submitted by: Joanne McClune, ward sister, Maynard Sinclair Ward, Ulster Hospital, South Eastern Health and Social Care Trust
Bronchiolitis strongly contributes to winter pressures, impacting on acute paediatric services and on bed availability and patient flow in children’s wards. Not only that, it also adds to pressures on both nursing and medical staff and to the distress of babies and their families. At the Ulster Hospital, South Eastern Health and Social Care Trust, the children’s ward, known as the Maynard Sinclair Ward, consists of 20 beds, however often due to winter pressures and the addition of bronchiolitis, this overflows into the surgical ward impacting upon their service provision.
In 2018-19 a quality improvement (QI) project was undertaken by the ward to implement NICE guidance on Recommendations for Bronchiolitis in children: diagnosis and management (NG9). which provides recommendations on the diagnosis and management of bronchiolitis, admission criteria and discharge criteria. The team mapped out the patient’s journey from presenting at A&E to their eventual discharge and chose to focus on 3 clinical areas, the emergency department, the Children’s Short Stay Ward and the Maynard Sinclair Ward. They brought together a multidisciplinary team made up of staff with different areas of expertise and levels from all 3 clinical areas.
The project focussed on implementing NICE recommendations and aimed to achieve the following goals for infants under 1 year old with bronchiolitis:
- increase staff adherence to the guideline by 50% by March 2019
- decrease unnecessary interventions by 50% by March 2019
Implementing the recommendations has involved considerable change to everyday medical and nursing practice and the traditional way that infants with bronchiolitis have been cared for. Clinical interventions i.e. routine suction, or using certain medications, are no longer advised and the focus is now on minimal interventions. As such, opportunities to improve the overall efficiency of their service and provision of care for babies with bronchiolitis, including bed availability and patient flow, has improved. Nursing staff have found they have more time back by no longer focusing on unnecessary interventions and cost savings have resulted with the use of less interventions and medications.
All the initial aims that the team set out were achieved and, in fact, greatly exceeded. When compared to the winter period in 2017-18 where 89% of babies with bronchiolitis were receiving unnecessary clinical interventions, the use of the recommendations has seen these incidences reduced to 0%. Staff knowledge and adherence to the guidance also increased and confidence in caring for babies with bronchiolitis increased from 33% to 96%.
NICE guidance continues to be followed and good working relationships have been forged between the emergency department and children’s unit which are helping to bring about further improvements in care.
“The collaboration between our paediatric medical team and our emergency department during this project has greatly enhanced shared learning between us and increased confidence in managing bronchiolitis during a busy winter period. By listening to our teams, it was the simple things such as easily read posters and postcards with target observations and feed volumes that supported the greatest of change in our practice,” Dr Bernadette O'Connor, associate clinical director for paediatrics, consultant paediatrician.
- This work will be presented at the awards taking place virtually on Thursday 12 November, where the audience will be voting for the winner. Find out more about the event and how to register at www.nice.org.uk/news/events.
To find out more about this shared learning example here: https://www.nice.org.uk/about/what-we-do/into-practice/shared-learning-case-studies/shared-learning-awards/shared-learning-awards-2020/shared-learning-awards-2020-finalist---bronchiolitis--when-less-is-more
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Update on the NICE ME/CFS guideline roundtable discussion22/09/2021 09:10:00
The roundtable meeting to discuss the updated guideline on the diagnosis and management of ME/CFS will be held on October 18th in London. It is being convened after publication of the guideline was paused when issues were raised by some professional groups during the pre-publication period
NICE and PHE recommend all employers give mental health training for managers17/09/2021 11:10:00
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
NICE recommends treatment for people with juvenile idiopathic arthritis10/09/2021 11:15:00
NICE yesterday (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
Professor Gillian Leng to retire from NICE09/09/2021 14:15:00
Professor Leng has spent more than 20 years working at NICE.
NICE draft guidance recommends apalutamide for treating prostate cancer08/09/2021 12:20:00
NICE has today (8 September 2021) published final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy for treating prostate cancer in adults
Sharing evidence with NICE is part of a broader approach to help Cochrane to identify priority reviews02/09/2021 11:15:00
Toby Lasserson, deputy editor in chief at Cochrane, writes about a new collaborative agreement with NICE, how it will work and what it means for the health service.
NICE approves ground-breaking cholesterol-lowering drug inclisiran01/09/2021 13:05:00
NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke
NICE and Cochrane sign collaborative agreement to deliver ‘living’ guideline recommendations01/09/2021 12:05:00
NICE and Cochrane have today (01st September 2021) signed a collaborative agreement which will help to deliver ‘living’ recommendations across the NICE guideline portfolio.
NICE announces next steps for ME/CFS guideline31/08/2021 09:15:00
NICE recognises the importance to patients of the updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) and is keen to move forwards as quickly as possible.